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Dear Editor,
Leonardi and Rosa’s (2010) research on the link between 
celiac disease and viral hepatitis (1) is well designed and fo-
cuses on a very interesting topic. Several de novo or latent 
autoimmune disorders or diseases have been reported in 
cases of chronic viral hepatitis infections, especially Hepati-
tis C (2). In this paper, we report 5 cases of established perni-
cious anemia during chronic viral hepatitis infection. These 
cases  were  extracted  from  a  retrospective  (1996  to  2010) 
study  of  82  cases  of  pernicious  anemia  in  the  University 
Hospital of Strasbourg, France, a tertiary reference center 
(personal  communication  in  the  French  Congress  of  He-
matology, Paris, December, 2010). Clinical characteristics of 
the 5 patients are described in table 1, particularly details on 
hepatitis infection, modalities of the interferon-alpha treat-
ment, and data on the cobalamin deficiency related to the 
pernicious anemia. Data of 3 patients were previously pub-
lished in the literature (3). It is important to note that, in one 
case, an association was found between pernicious anemia, 
true celiac disease, and chronic actve Hepatitis C infection. 
All the patients were successfully treated with regular in-
tramuscular cyanocobalamin therapy (despite continuous 
administration of interferon-alpha in 2 cases). To the best 
of our knowledge, there are only a relatively small amount 
of cases (< 10 in our own data) documenting a relationship 
between symptomatic pernicious anemia and viral hepatitis 
infections. Our patients had established pernicious anemia 
with documented cobalamin deficiency (in accordance with 
recent criteria; (4)). They also have a clear chronic active viral 
hepatitis infection on liver biopsy (1 case of Hepatitis B and 
4 cases of Hepatitis C). Moreover, one of our patients had a 
well-documented case of celiac disease with malabsorption 
and antitransglutamise antibodies, partially cured with nu-
tritional restrictions (no gluten intake). The pathogenis (the 
link) of this association is not well known, but the role of the 
virus or of the interferon-alpha treatment as an immuno-
modulatory agent is possible (5). However in our opinion, 
the fact that this association is exceptional led to the suspi-
cion of a fortuitous association. Thus before any conclusions 
can be made, future studies similar to Leaonardi and Rosa 
(2010) are required. Nevertheless, it is important to be aware 
of the possibility of the association between pernicious ane-
mia and chronic viral hepatitis infections because recogni-
tion of this association can help prevent severe cobalamin 
deficiency.
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Age (years), 
sex
Data on viral hepatitis
Data on cobalamin deficiency related to pernicious               
anemia
Other autoimmune dis-
orders
52, F Chronic active hepatitis 
B followed since at least 5 
years of age with no treat-
ment
Cobalamin deficiency:
• Loss of reflexes 
• Megaloblastic anemia
• Serum vitamin B12 level <130 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Autoimmune atrophic gastritis
Hashimoto’s thyroïd with 
anti-TPO antibodies a
45, M Chronic active hepatitis 
C followed since 5 years 
of age and treated with 
interféron-α: 9 MU per 
week (subcutaneously)
Cobalamin deficiency:
• Medullar combined sclerosis
• No hematological abnormality
• Serum vitamin B12 level <22 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Malabsorption on the de Schilling’s test reversed with 
intrinsic factor b
• Autoimmune atrophic gastritis
58, F Chronic active hepatitis 
C treated since 7 months 
of age with interféron-α: 
9 MU per week (subcuta-
neously)
Cobalamin deficiency:
• Loss of reflexes
• Megaloblastic anemia and thrombocytopenia 
• Serum vitamin B12 level <150 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
Asymptomatic cryoglobu-
linemia
82, M Mild chronic hepatitis C 
with no interferon-alpha 
treatment
Cobalamin deficiency:
• Sensitive peripheral neuropathy
• Megaloblastic anemia
• Serum vitamin B12 level <20 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
• Autoimmune atrophic gastritis
Antinuclear antibodies a
38, M Chronic hepatitis C with 
no interferon-alpha treat-
ment
Cobalamin deficiency:
• Sensitive peripheral neuropathy
• Macrocytosis (MCV = 105 fL)
• Serum vitamin B12 level <160 pg/mL a
Pernicious anemia:
• Anti-intrinsic factor antibodies a
Celiac disease with malab-
sorption (iron, folate and 
calcium), duodal villous 
atrophy and antitransgluta-
minase antibodies a
Table 1. Characteristics of the patients
a Serum vitamin B12 levels were determined by radioimmunoassay (Bayer, New York, NY, USA). 
b Schilling’s test was realized with a Dicopac test (Amersham Healthcare, Birmingham UK).